Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

New Method Grows Brain Cells From Stem Cells Quickly and Efficiently

By Lund University | August 22, 2018

Researchers at Lund University in Sweden have developed a faster method to generate functional brain cells, called astrocytes, from embryonic stem cells. Astrocytes play a significant role in neurodegenerative diseases. The new method reduces the time required to produce the cells from months to two weeks, and the study has been published in Nature Methods.

“This means that it is now easier than before to study the role of astrocytes in various diseases”, says Henrik Ahlenius, who led the research team.

Even though the presence in our brain of the star-shaped glial cells, known as astrocytes, has been known for a long time, it has only recently been discovered how significant these brain cells actually are. Instead of only having a support function, as previously thought, the cells play an important role in the normal brain and in conditions such as dementia diseases and ALS.

One challenge that researchers have faced is the difficulty in obtaining human astrocytes to study. There are ways to grow astrocytes in the lab, but it has taken a long time and proved difficult, expensive and complicated. Until now.

“Previous methods have succeeded in producing human astrocytes from embryonic stem cells, but it has taken months. Using our method, it takes one to two weeks to produce large amounts of fully functional human astrocytes”, says Henrik Ahlenius.

Simply put, Henrik Ahlenius and his research team show how it is possible to use viruses to activate genes in the embryonic stem cells, which during normal development regulate how the astrocytes are formed. In this way, the researchers have succeeded in making the embryonic stem cells rapidly form astrocytes.

“Many researchers have previously used embryonic stem cells to generate astrocytes, but these methods have attempted to mimic the normal development of an embryo’s stem cell when developing an astrocyte in an individual, which requires a time-consuming and complicated approach”, says Henrik Ahlenius.

The astrocytes produced from the embryonic stem cells are very similar to the astrocytes in the brain of adult humans, in terms of appearance, genetic profile and function.

The cells’ use in studying diseases of the brain has been shown by the research team through employing CRISPR-Cas9, popularly known as gene editing, to insert a mutation in the embryonic stem cells that gives rise to the serious brain condition Alexander disease. They subsequently used the new method to change healthy and mutated stem cells into astrocytes.

When the researchers compared the astrocytes, it was shown that cells with the mutation exhibited several defects previously known to be present among those suffering from Alexander disease. “Using this approach of combining CRISPR-Cas9 and our method to rapidly grow human astrocytes provides improved possibilities to study the role of astrocytes in various neurological diseases”, says Henrik Ahlenius.

The research team’s main focus is studying age-related neurodegenerative diseases such as dementia and Alzheimer’s, and the next step will be to use the method to examine the significance of astrocytes in these diseases.


Filed Under: Genomics/Proteomics

 

Related Articles Read More >

Spatial biology: Transforming our understanding of cellular environments
DNA double helix transforming into bar graphs, blue and gold, crisp focus on each strand, scientific finance theme --ar 5:4 --personalize 3kebfev --v 6.1 Job ID: f40101e1-2e2f-4f40-8d57-2144add82b53
Biotech in 2025: Precision medicine, smarter investments, and more emphasis on RWD in clinical trials
DNA helix 3D illustration. Mutations under microscope. Decoding genome. Virtual modeling of chemical processes. Hi-tech in medicine
Genomics in 2025: How $500 whole genome sequencing could democratize genomic data
A media release and Scientific Report image of Elizabeth Kellogg. - Camera Settings: ILCE-9M2, 12mm, ISO 1000, 1/80, f/3.2, Fri, 04-19-2024 at 10:10. v.12.01.23
St. Jude pioneers gene editing and structural biology to advance pediatric research
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE